These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 36166246

  • 1. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome.
    Liern M, Colazo A, Vallejo G, Zotta E.
    Nefrologia (Engl Ed); 2021; 41(3):304-310. PubMed ID: 36166246
    [Abstract] [Full Text] [Related]

  • 2. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome.
    Liern M, Colazo A, Vallejo G, Zotta E.
    Nefrologia (Engl Ed); 2021; 41(3):304-310. PubMed ID: 33722403
    [Abstract] [Full Text] [Related]

  • 3. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
    [Abstract] [Full Text] [Related]

  • 4. Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.
    Caletti MG, Balestracci A, Missoni M, Vezzani C.
    Pediatr Nephrol; 2013 May; 28(5):745-50. PubMed ID: 23250713
    [Abstract] [Full Text] [Related]

  • 5. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Cas Lek Cesk; 1999 Oct 20; 138(18):560-4. PubMed ID: 10596472
    [Abstract] [Full Text] [Related]

  • 6. Enalapril: antiproteinuric effect in children with nephrotic syndrome.
    Lama G, Luongo I, Piscitelli A, Salsano ME.
    Clin Nephrol; 2000 Jun 20; 53(6):432-6. PubMed ID: 10879662
    [Abstract] [Full Text] [Related]

  • 7. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C.
    Pediatr Nephrol; 2013 May 20; 28(5):737-43. PubMed ID: 23207876
    [Abstract] [Full Text] [Related]

  • 8. Anti-proteinuric effects of combination therapy with enalapril and losartan in patients with nephropathy due to type 2 diabetes.
    Cetinkaya R, Odabas AR, Selcuk Y.
    Int J Clin Pract; 2004 May 20; 58(5):432-5. PubMed ID: 15206496
    [Abstract] [Full Text] [Related]

  • 9. Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Med Sci Monit; 2002 Feb 20; 8(2):BR69-74. PubMed ID: 11859270
    [Abstract] [Full Text] [Related]

  • 10. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
    Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM.
    Am J Kidney Dis; 2001 Jul 20; 38(1):18-25. PubMed ID: 11431176
    [Abstract] [Full Text] [Related]

  • 11. Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
    Proesmans W, Van Dyck M, Devriendt K.
    Nephrol Dial Transplant; 2009 Apr 20; 24(4):1335-8. PubMed ID: 19147669
    [Abstract] [Full Text] [Related]

  • 12. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.
    Kidney Int; 2012 Oct 20; 82(7):819-26. PubMed ID: 22739977
    [Abstract] [Full Text] [Related]

  • 13. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome.
    Nakhoul F, Khankin E, Yaccob A, Kawachi H, Karram T, Awaad H, Nakhoul N, Hoffman A, Abassi Z.
    Am J Physiol Renal Physiol; 2008 Mar 20; 294(3):F628-37. PubMed ID: 18094029
    [Abstract] [Full Text] [Related]

  • 14. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L, Rutkowski P, Renke M, Rutkowski B.
    Am J Nephrol; 2002 Mar 20; 22(4):356-62. PubMed ID: 12169868
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome.
    Akman S, Kalay S, Akkaya B, Koyun M, Akbaş H, Baysal YE, Guven AG.
    Pediatr Nephrol; 2009 Jun 20; 24(6):1173-80. PubMed ID: 19224250
    [Abstract] [Full Text] [Related]

  • 16. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W.
    Med Sci Monit; 2005 Apr 20; 11(4):PI31-7. PubMed ID: 15795705
    [Abstract] [Full Text] [Related]

  • 17. Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats.
    Blezer EL, Nicolay K, Koomans HA, Joles JA.
    Am J Hypertens; 2001 Jan 20; 14(1):54-61. PubMed ID: 11206680
    [Abstract] [Full Text] [Related]

  • 18. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
    Supavekin S, Surapaitoolkorn W, Tancharoen W, Pattaragarn A, Sumboonnanonda A.
    Pediatr Int; 2012 Dec 20; 54(6):793-7. PubMed ID: 22621380
    [Abstract] [Full Text] [Related]

  • 19. Enalapril treatment of proteinuria in normotensive children.
    Sasinka MA, Podracka L, Boor A, Jurkovic I, Mitro A, Kovacs L.
    Bratisl Lek Listy; 1999 Sep 20; 100(9):476-80. PubMed ID: 10645036
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G, Filiopoulos V, Georgoulias C, Tentolouris N, Michail S.
    Scand J Urol Nephrol; 2010 Sep 20; 44(4):251-6. PubMed ID: 20201749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.